CClinicalTrials.gg
CompletedNCT02611479Updated May 30, 2019Results posted

Understanding Non-Response in Spine Fusion Surgery

An observational study in Spine Fusion, sponsored by University of Washington. Completed at 4 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-05-30.

Sponsored by University of Washington · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
184
Ages
18 Years and older
Sex
All
01

Study summary

To identify patient characteristics associated with non-response after spine fusion surgery for the treatment of degenerative disc disease (DDD).

02

Conditions studied

  • Spine Fusion

Keywords

  • patient reported outcomes
03

In context

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults (18 and over) undergoing spine fusion surgery in Washington State.

Inclusion criteria

  • Subject has diagnosis of degenerative disc disease
  • Subject is undergoing lumbar spine fusion surgery

Exclusion criteria

Exclusion Criteria:

  • Subject is less than 18 years of age
  • Subject is not fluent in English
  • Subject requires a caretaker for medical decision making
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
184 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Oswestry Disability Index

    Change in pain and function after spine fusion surgery was measured by the Oswestry Disability Index. Scores range from 0 to 100. The questionnaire has 10 questions about pain intensity, personal care, lifting ability, walking ability, sitting ability, standing ability, sleeping ability, sex ability, social life, and travelling. Each question is followed by 6 options which describe the amount of disability a patient may face in these situations and the patient marks the statement most applicable to them. Each question is scored on a scale (0-5) with the first option "0" indicating the least amount of disability and "5" indicating the most severe disability. Higher scores indicate worse outcomes, lower scores indicate better outcomes.

    Time frame: Baseline, 60 day, 1 year

07

Results

Posted May 30, 2019
Limitations and caveats
Clinical variables were collected from SCOAP which is a quality improvement database and variables are not as reliable as research variables. It is unknown if participants that did not complete the surveys would have responded to surgery or not.

Participant flow

Baseline Enrollment
Participant flow — Baseline Enrollment
MilestoneSpine Fusion Participants
Started184
Completed171
Not completed13
Withdrew: Exited study13
Post-Surgery Follow-up at 30-90 Days
Participant flow — Post-Surgery Follow-up at 30-90 Days
MilestoneSpine Fusion Participants
Started171
Completed169
Not completed2
Withdrew: No surgery reported2
Post-Surgery Follow-up at 1-Year
Participant flow — Post-Surgery Follow-up at 1-Year
MilestoneSpine Fusion Participants
Started169
Completed151
Not completed18
Withdrew: Lost to follow-up18
Data Cleaning
Participant flow — Data Cleaning
MilestoneSpine Fusion Participants
Started151
Completed149
Not completed2
Withdrew: No baseline function or pain metrics2

Outcome measures

PrimaryOswestry Disability Index

Change in pain and function after spine fusion surgery was measured by the Oswestry Disability Index. Scores range from 0 to 100. The questionnaire has 10 questions about pain intensity, personal care, lifting ability, walking ability, sitting ability, standing ability, sleeping ability, sex ability, social life, and travelling. Each question is followed by 6 options which describe the amount of disability a patient may face in these situations and the patient marks the statement most applicable to them. Each question is scored on a scale (0-5) with the first option "0" indicating the least amount of disability and "5" indicating the most severe disability. Higher scores indicate worse outcomes, lower scores indicate better outcomes.

Time frame:
Baseline, 60 day, 1 year
Reported as:
Mean · score on a scale
Oswestry Disability Index
score on a scaleSpine Fusion Participants
Baseline41.3 ± 15.4
60-day30.4 ± 17.1
12-month19.4 ± 17.3

Adverse events

Collected over Adverse Events not tracked and are inapplicable to this study.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Spine Fusion Participants———

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Spine Fusion Participants
<=18 years0
Between 18 and 65 years71
>=65 years78
Sex: Female, Male
Sex: Female, Male(Participants)Spine Fusion Participants
Female83
Male65
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Spine Fusion Participants
Hispanic or Latino5
Not Hispanic or Latino144
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Spine Fusion Participants
American Indian or Alaska Native2
Asian5
Native Hawaiian or Other Pacific Islander0
Black or African American0
White140
More than one race2
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Spine Fusion Participants
United States149
Functional Limitations from back pain (ODI)
Functional Limitations from back pain (ODI)(units on a scale)Spine Fusion Participants
Mean41.3 ± 15.4
Anxiety
Anxiety(T-scores)Spine Fusion Participants
Mean55.0 ± 9.2
Depression
Depression(T-scores)Spine Fusion Participants
Mean52.5 ± 9.6

11 further baseline measures are reported on the registry.

08

Study locations

4 sites
  • University of Washington
    Seattle, Washington 98105, United States
  • Proliance Surgeons
    Seattle, Washington 98122, United States
  • Swedish Medical Center
    Seattle, Washington 98122, United States
  • Confluence Health
    Wenatchee, Washington 98801, United States
09

References and documents

Related links

Study documents

  • Study protocol · Feb 6, 2019
  • Statistical analysis plan · Feb 6, 2019

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 30, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02611479
Lead sponsor
University of Washington
Collaborators
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Responsible party
David Flum (Medical Director, Surgical Outcomes Research Center, University of Washington) — Principal investigator
First posted
Nov 20, 2015
Start date
Apr 2015
Primary completion
Aug 2017
Completion
Jun 2018
Results posted
May 30, 2019
Last update
May 30, 2019

Study contacts

Amy M Cizik, MPH, PhC
study director · University of Washington

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion